LADARVISION 8065490006

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2007-04-25 for LADARVISION 8065490006 manufactured by Alcon - Orlando Technology Center.

Event Text Entries

[620040] A surgeon reports a patient that is overcorrected following refractive surgery. Patient records were provided and indicate at 6 months post-op, this patient exhibited a 1d overcorrection in the left eye and bcva in the left eye decreased from 20/20 pre-op to 20/25. An enhancement was performed 8 months following the initial procedure. At approximately 6 weeks post-enhancement, the overcorrection had resolved; however, bcva was now 20/40. Ucva improved from 20/cf pre-op to 20/50-2 at 6-weeks post-enhancement.
Patient Sequence No: 1, Text Type: D, B5


[7867298] Determination of root cause: assessment: a surgery database performance verification was conducted on this system. The analysis indicated the laser performance factors analyzed were operating within specification during this patient's surgeries. Patient records were reviewed for non-product factors including patient response to the later ablation, patient healing characteristics and preoperative patient selection. No specific non-product factors could be identified or the initial overcorrection noted. Following the enhancement, the records indicate postoperative complications for the left eye indicating a flap lift-refloat and refractive instability. The records do not indicate any potential contributing factors for the decreased bcva in the left eye; however, pre-enhancement measurements as well as the post-enhancement topographies suggest a thin cornea for the left eye. It is not uncommon for the cornea to demonstrate a hyperopic-astigmatic refractive error secondary to corneal thinning. Conclusion: based on the results of the investigation of product and non-product factors, the device was not found to be a contributor to the decrease in bcva. However, the non-product related factors mentioned above may have been contributors.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1061857-2007-00173
MDR Report Key844007
Report Source05
Date Received2007-04-25
Date of Report2006-12-06
Date of Event2006-02-23
Date Mfgr Received2007-03-14
Device Manufacturer Date2000-10-01
Date Added to Maude2007-05-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactSHERRI LAKOTA
Manufacturer Street2501 DISCOVERY DR, STE 500
Manufacturer CityORLANDO FL 32826
Manufacturer CountryUS
Manufacturer Postal32826
Manufacturer Phone4073841644
Manufacturer G1ALCON-ORLANDO TECHNOLOGY CTR.
Manufacturer Street2501 DISCOVERY DR, STE 500
Manufacturer CityORLANDO FL 32826
Manufacturer CountryUS
Manufacturer Postal Code32826
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameLADARVISION
Generic NameOPHTHALMIC EXCIMER LASER SYSTEM
Product CodeDZS
Date Received2007-04-25
Model NumberNA
Catalog Number8065490006
Lot NumberNA
ID Number5.5.0
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key831178
ManufacturerALCON - ORLANDO TECHNOLOGY CENTER
Manufacturer Address2501 DISCOVERY DRIVE SUITE 500 ORLANDO FL 32826 US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2007-04-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.